How Stochastic %D predicts the worthiness of Interpace Diagnostics Group, Inc. (NASDAQ:IDXG)?

103

Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) for the period of 9-Day stands at 34.21% while the stochastic %D for the same period stands at 41.73%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) signals “Buy” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) while 20-100 Day MACD Oscillator indicates “Buy”.

Bollinger band is a volatility indicator of a certain security, currently Interpace Diagnostics Group, Inc. (NASDAQ:IDXG)’s 20-Day Bollinger Band indicates “Hold”.

About Company

Interpace Diagnostics Group, Inc. provides molecular diagnostic tests. The company’s test consists of ThyGenX Thyroid Oncogene Panel (R), Thyroid miRNA(TM) and PancraGen(TM). Interpace Diagnostics Group Inc, formerly known as PDI Inc., is headquartered in Parsippany, New Jersey.

Previous Day Activity Analysis

On the last trading day, Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) opened the session at $1.53 and after going down -5.73% closed at $1.48. The stock lost -0.05 points in the last trade.

Interpace Diagnostics Group, Inc. (NASDAQ:IDXG)’s stock fluctuated in the range of $1.47 and $1.54 during the previous active session. Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) traded with the volume of 1.74 Million with average volume of 3.11 Million. The stock has LOW volatility on the last trading session.

Currently the Beta for the company remains at 1.7 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.14 and 47.73 respectively.

Currently the Insider Ownership of the shares of Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) is at 2.39% and the shares outstanding are 23.51 Million.

Important Ratio Analysis

Some important ratios to consider here for Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) are discussed below:

Dividend yield of Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) stands at 0% whereas Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The PEG ratio (Price to Earning to Growth) emits the value of 0. The Price to Sale P/S and Price to Book P/B shows the value of 2.52 and 0.26 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 0 and 0 correspondingly.

The Quick Ratio of Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) stands at 0.8 while the Current Ratio depicts the value of 0.8.

Return on Assets ROA of Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) is at -17.7% whereas, Return on Equity ROE and Return of Investment ROI of Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) stand at -93.6% and -43.6% respectively.

Stock Performance Analysis

The stock performance of Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) on the basis of 5 day trade show the dip of -8.64% whereas, the monthly performance of the stock shows increase of 4.96%.

The quarterly performance of the stock remained in green zone with the value of 67.23% while six month performance of the shares of Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) remained bearish with the count of -31.16%.

The yearly and YTD performance of Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) remained down at -16.9% and -66.36% respectively.